Authors: Bennett Yang, Joel Moss
Published: 2023-05-10
Source: Full article
Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.